Literature DB >> 22724573

Melanotan-associated melanoma in situ.

Suyin Ong1, Jonathan Bowling.   

Abstract

Injectable synthetic melanotropic peptides (often called melanotan) to enhance tanning are available over the Internet despite being unlicensed compounds with an unproven safety record. There have been reports of dysplastic naevi and melanoma associated with the use of melanotropic peptides. We report a case of melanotan-associated melanoma in situ.
© 2012 The Authors. Australasian Journal of Dermatology © 2012 The Australasian College of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22724573     DOI: 10.1111/j.1440-0960.2012.00915.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  3 in total

Review 1.  [Undesirable pigmentation].

Authors:  C Bayerl
Journal:  Hautarzt       Date:  2015-10       Impact factor: 0.751

Review 2.  Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.

Authors:  Elisabeth I Minder; Jasmin Barman-Aksoezen; Xiaoye Schneider-Yin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

Review 3.  Topical treatment strategies to manipulate human skin pigmentation.

Authors:  Inbal Rachmin; Stephen M Ostrowski; Qing Yu Weng; David E Fisher
Journal:  Adv Drug Deliv Rev       Date:  2020-02-21       Impact factor: 15.470

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.